$Voyager Therapeutics (VYGR.US)$I got in on this around April of this year for around $6.30-6.40 and have been holding it just waiting for it to completely crash. I'm not sure exactly what caused the uptick today but I do know I'm extremely tempted to sell it all off and take the smaller profits (actually I'm definitely going to sell some for that), but I'm not sure, I think this company still has potential long-term, I was just blown away by how stagnant it had been for months. Anyone else have...
4
5
Report
climbing capy
:
similar thoughts especially when yesterday i was down 15% but since company is doing great financially, decided to hold and wait.
BeeDeeVee712
OP
climbing capy
:
You literally described the back and forth I've been having in my head...I don't get why it hasn't moved (technically has dropped) after looking through and following up on their financials, they seem rather strong and I'm not really finding any sufficient reason to explain the lack of growth, especially over a period of months, you know?
BeeDeeVee712
OP
climbing capy
:
Are you still holding onto this? I'm starting to feel better than I was in early October...I'm not exactly sure what contributed to this sharp increase over the past few days, but I'll take it!
$Voyager Therapeutics (VYGR.US)$ This was over $10 recently, and earnings were great, except Wall St was scared of recession at the time. I'm guessing once they are satisfied, this will go back up
$Voyager Therapeutics (VYGR.US)$Press Release: Voyager Enters Into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14 Dow Jones· 2 mins ago Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14 Voyager to receive upfront consideration of $15 million and is eligible to receive up to $305 million in potential associated milestone payments and royalties
$Voyager Therapeutics (VYGR.US)$ Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14 Voyager Therapeutics (Nasdaq: VYGR) has announced a new license agreement with Novartis AG (NYSE: NVS) for a novel capsid from Voyager's TRACER™ capsid discovery platform. The capsid will be used in a gene therapy program targeting an undisclosed rare neurologic disease. This agreement expands Voyager's partnered portfolio of TRACER-enabl...
$Voyager Therapeutics (VYGR.US)$Man, I've been holding this for awhile (since late Q1 this year) and it just can't ever seem to get that boost and then that second boost that I was really expecting to come by the end of summer. I guess there's still time and I'm only in @ $7.15 or so, so it could definitely be worse. I'm still expecting this to take off at some point.
$Voyager Therapeutics (VYGR.US)$Finally some movement on this one I bought in at just under $8 a few months ago and have just been holding while this has seemly remained stagnant. Hopefully today's movement is a nice sign of what is to come 😁.
4
1
Report
Trytosaveabit
:
If you’re still holding? Phase 1a study safety data is expected in the second half of 2024. So that could be anytime now. If that looks great, it could prove to be a decent catalyst. GL
LEEER利爾 OP : Good news, it’s time to surge![fire 🔥](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f525.png)
![fire 🔥](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f525.png)
![rocket 🚀](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f680.png)
![rocket 🚀](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f680.png)
![rocket 🚀](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f680.png)
![rocket 🚀](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f680.png)
![rocket 🚀](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f680.png)
![rocket 🚀](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f680.png)
![rocket 🚀](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f680.png)